The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer

被引:3
|
作者
Euhus, Caleb J. [1 ]
Ripley, Taylor R. [1 ]
Medina, Cristian G. [1 ]
机构
[1] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Thorac Surg, 1 Moursund St, Houston, TX 77030 USA
关键词
oligometastatic non-small cell lung cancer; metastatic non-small cell lung cancer; NSCLC history; lung cancer staging; surgery and NSCLC; local consolidative therapy (LCT); locally-aggressive therapy (LAT); LONG-TERM SURVIVAL; PROGNOSTIC-FACTORS; THERAPY; RADIOTHERAPY; CLASSIFICATION; MULTICENTER; PROGRESSION; METASTASIS; MANAGEMENT; RESECTION;
D O I
10.3390/cancers14102524
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary This article clarifies the context and definition of the term oligometastasis as it applies to non-small cell lung cancer and reviews the current results in the use of surgery for its management. Ideally after reading this article, practitioners will be better equipped to pick patients for locally aggressive therapy, and researchers will be primed to design the next generation of studies that prioritize treatments in the management of this historically deadly disease. Oligometastatic non-small cell lung cancer (NSCLC) is metastatic disease that refers to a limited number of metastatic sites. It is analogous to an intermediate stage of NSCLC, between localized and widely metastatic disease, even though no staging criteria establishes this distinction. Oligometastatic NSCLC describes a patient subgroup with limited metastasis to one or a few organs. These patients seem to have a more indolent cancer than those with diffuse metastasis. For these select patients with oligometastatic disease, the use of palliative systemic therapy over local aggressive treatment may be a missed opportunity to improve survival. The clear definition of this subgroup and identification of the best treatment remains the current challenge in the management of the disease. Surgery was the early cornerstone in the treatment of limited disease; however, as modalities such as chemotherapy, stereotactic radiosurgery, and immunotherapy have matured, the role of excision is less clearly defined. There are sparse randomized controlled trials comparing the efficacy of different treatment modalities in patients with oligometastatic NSCLC. However, there is a growing body of retrospective research detailing the prognostic factors that characterize the role of surgery in the management of these patients. This article clarifies the context and definition of the term oligometastatic, as it applies to NSCLC, and reviews the current results in the use of surgery for its management.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Surgery for oligometastatic non-small cell lung cancer
    Antonoff, Mara B.
    Deboever, Nathaniel
    Werner, Raphael
    Altan, Mehmet
    Gomez, Daniel
    Opitz, Isabelle
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 167 (02):
  • [2] CURATIVE SURGERY IN OLIGOMETASTATIC NON-SMALL CELL LUNG CANCER PATIENTS
    Rijavec, Erika
    Merlo, Valentina
    Aita, Marianna
    Menis, Jessica
    Sibau, Angela
    Follador, Alessandro
    Beer, Zsuzsanna
    Gaiardo, Marica
    Fasola, Gianpiero
    ANNALS OF ONCOLOGY, 2009, 20
  • [3] Surgery for Locally Advanced and Oligometastatic Non-Small Cell Lung Cancer
    Coster, Jenalee N.
    Groth, Shawn S.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 29 (04) : 543 - 554
  • [4] The Significance of Surgery for Oligometastatic and Oligoprogressive Non-small Cell Lung Cancer
    Schmid, Severin
    Passlick, Bernward
    ZENTRALBLATT FUR CHIRURGIE, 2017, 142 : S38 - S43
  • [5] Curative surgery in oligometastatic non-small cell lung cancer patients
    Merlo, V.
    Rijavec, E.
    Aita, M.
    Menis, J.
    Rizzato, S.
    Rossetto, C.
    Beer, Z.
    Gaiardo, M.
    Fasola, G.
    EJC SUPPLEMENTS, 2009, 7 (02): : 518 - 519
  • [6] The role of surgery in oligometastatic non-small-cell lung cancer
    Lampridis, Savvas
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2021, 59 (04) : 926 - 926
  • [7] Oligometastatic non-small cell lung cancer: is there a role for locoregional therapy?
    Berzenji, Lawek
    Van Schil, Paul E.
    JOURNAL OF THORACIC DISEASE, 2017, 9 (07) : 1814 - 1817
  • [8] Commentary: Keeping surgery relevant in oligometastatic non-small cell lung cancer
    Donington, Jessica S.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 157 (04): : 1629 - 1630
  • [9] Oligometastatic disease of non-small cell lung cancer
    Schmid, Severin
    Passlick, Bernward
    Stuschke, Martin
    Griesinger, Frank
    ONKOLOGE, 2018, 24 (12): : 992 - 1002
  • [10] SBRT for Oligometastatic Non-Small Cell Lung Cancer
    Herman, M. P.
    Dagan, R.
    Yeung, A. R.
    Bryant, C.
    Morris, C. G.
    Okunieff, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S609 - S610